Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Obesity drugmaker Novo Nordisk downgraded its 2025 sales forecast on ...

Novo Nordisk (NYSE:NVO) trimmed its full-year 2025 sales and profit forecast on Wednesday, citing weaker-than-expected U.S.

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

The company has seen sales hit by alternative compounded versions of its blockbuster weight-loss and diabetes drugs, ...

A look at the day ahead in European and global markets from Tom Westbrook After a few weeks buying the rumour of U.S.-China ...

German premium carmaker BMW on Wednesday confirmed its 2025 outlook, saying it expected some of the tariffs that have been ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Obesity drugmaker Novo Nordisk on Wednesday cut its full-year sales and profit outlook amid lacklustre U.S. prescription data ...

Japanese drugmaker Shionogi plans to acquire Torii Pharmaceutical for about 150 billion yen ($1.01 billion), the Nikkei ...

A look at the day ahead in European and global markets from Tom Westbrook After a few weeks buying the rumour of U.S.-China de-escalation, markets gave a lukewarm welcome to news that the countries' ...

Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in ...

AI server maker Super Micro Computer forecast fourth-quarter revenue below Wall Street estimates on Tuesday and said economic ...